1. M. Bauer, L. de Leede, and M. V. D. Waart, Eur. J. Pharm. Sci.,
6, 331 – 335 (1998).
2. Impurities in New Drug Substances, ICH Guideline Q3A (R), International Conference on Harmonization (ICH), (2002).
3. Impurities in New Drug Substances, ICH Guideline Q3B (R), International Conference on Harmonization (2002).
4. M. Blessy, R. D. Patel, P. N. Prajapati, and Y. K. Agrawal, J. Pharm. Anal., 4, 159 – 165 (2014).
5. The European Pharmacopoeia, 4th edition, Council of Europe, Strasbourg (2002).